Anteris Technologies Global Corp. aims to raise $75 million in an IPO for aortic stenosis treatment development in a growing ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development ...

Edwards Lifesciences (NYSE:EW) today announced its plans for significant growth as a purely structural heart company in 2025.

which is anticipated to offer fresh insights for global implanters treating symptomatic severe aortic stenosis (SASS). The ...

A recent study has revealed a strong link between insulin resistance and an increased risk of aortic stenosis (AS), a ...

In the CONDUCT-TAVI study, the use of a self-expanding valve was not associated with an increased risk of pacemaker.

Insulin resistance can increase the risk of aortic stenosis -- a common heart valve disease, in men over the age of 45, finds ...

Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, ...

Insulin resistance associated with prediabetes appears to raise a person’s risk of a common and serious heart valve ...

Edwards Lifesciences (EW) reaffirmed original 2024 total company constant currency sales growth guidance of 8% to 10%. The company is ...

Dale Hamer, a veteran NFL official who later served as a replay official, has passed away at the age of 87. Hamer died on ...

FY24 consensus $5.83B. “It is an exciting day for Edwards as we share our vision for 2025 and how our talented team and focus in structural ...